Patient Guide: Study to Determine Recommended Phase 2 Dose of Intravenous (IV) Eftozanermin Alfa in Combination With IV or Subcutaneous (SC) Bortezomib and Oral Dexamethasone Tablet and to Assess Change in Disease Symptoms in Adult Participants With Relapsed or Refractory Multiple Myeloma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 19 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04570631
Status: TERMINATED
Condition: Multiple Myeloma
Phase: PHASE1

Find a Study Location Near You

This study is available at 19 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Atlanta, Georgia
  • Louisville, Kentucky
  • Boston, Massachusetts
  • • And 16 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily